A study to assess how Itraconazole affects the uptake and elimination of Capivasertib in the body

Trial Identifier:	D3614C00004
Sponsor:	AstraZeneca
Collaborator:	Parexel International
NCTID::	NCT04712396
Start Date:	February 2021
Primary Completion Date:	March 2021
Study Completion Date:	March 2021

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	German Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Germany	Berlin, Germany, 14050

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.